.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The SAFE trial compared 4% albumin with normal saline for intravascular volume resuscitation in almost 7,000 critically ill adults. Mortality at 28 days was similar between the two groups, and there were no significant differences in ICU or hospital length of stay, duration of mechanical ventilation or use of renal-replacement therapy. The study provided high-quality evidence that, across a broad ICU population, albumin did not confer an overall survival advantage over saline. SAFE is important because fluid choice is one of the most frequent decisions in critical care, yet physiologic reasoning does not always translate into better outcomes. The trial also highlights that effects can vary across subgroups: subsequent analyses suggested that patients with traumatic brain injury may be harmed by albumin-based resuscitation, illustrating why “equivalence” in a heterogeneous ICU population does not mean equivalence for every condition. For bedside practice, crystalloid remains the default resuscitation fluid for many patients, with albumin considered selectively when there is a specific clinical rationale. The larger lesson is that fluid therapy should be treated like any other drug: indication, dose, patient phenotype and cumulative exposure all matter.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The SAFE trial compared 4% albumin with normal saline for intravascular volume resuscitation in almost 7,000 critically ill adults. Mortality at 28 days was similar between the two groups, and there were no significant differences in ICU or hospital length of stay, duration of mechanical ventilation or use of renal-replacement therapy. The study provided high-quality evidence that, across a broad ICU population, albumin did not confer an overall survival advantage over saline. SAFE is important because fluid choice is one of the most frequent decisions in critical care, yet physiologic reasoning does not always translate into better outcomes. The trial also highlights that effects can vary across subgroups: subsequent analyses suggested that patients with traumatic brain injury may be harmed by albumin-based resuscitation, illustrating why “equivalence” in a heterogeneous ICU population does not mean equivalence for every condition. For bedside practice, crystalloid remains the default resuscitation fluid for many patients, with albumin considered selectively when there is a specific clinical rationale. The larger lesson is that fluid therapy should be treated like any other drug: indication, dose, patient phenotype and cumulative exposure all matter.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
